82 related articles for article (PubMed ID: 3146851)
1. [Differences in plasminogen activator species released from endothelial cells of different sites].
Nakashima Y
Nihon Ketsueki Gakkai Zasshi; 1988 Nov; 51(7):1214-8. PubMed ID: 3146851
[No Abstract] [Full Text] [Related]
2. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
[TBL] [Abstract][Full Text] [Related]
3. Gold labeling of urokinase plasminogen activator. Characterization and specific binding in cultured mammalian cells.
Dini G; Grappone C; Fibbi G; Magnelli L; Del Rosso M
J Submicrosc Cytol Pathol; 1991 Apr; 23(2):305-11. PubMed ID: 1906372
[TBL] [Abstract][Full Text] [Related]
4. Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system.
Chen PR; Lee CC; Chang H; Tsai CE
J Nutr Biochem; 2005 Jan; 16(1):59-64. PubMed ID: 15629242
[TBL] [Abstract][Full Text] [Related]
5. The expression of plasminogen activators and their inhibitors in cultured human retinal capillary endothelial cells.
Redmill BS; Booth NA; Knott RM; Forrester JV
Biochem Soc Trans; 1996 May; 24(2):206S. PubMed ID: 8736864
[No Abstract] [Full Text] [Related]
6. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
Korner G; Bjornsson TD; Vlodavsky I
J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
[TBL] [Abstract][Full Text] [Related]
7. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells.
Fibbi G; Ziche M; Morbidelli L; Magnelli L; Del Rosso M
Exp Cell Res; 1988 Dec; 179(2):385-95. PubMed ID: 2847935
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of vascular endothelial cell functions by vitamin A].
Kojima S; Inada Y
Tanpakushitsu Kakusan Koso; 1994 Jan; 39(1):66-73. PubMed ID: 7905651
[No Abstract] [Full Text] [Related]
9. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
[TBL] [Abstract][Full Text] [Related]
10. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells.
Pepper MS; Wasi S; Ferrara N; Orci L; Montesano R
Exp Cell Res; 1994 Feb; 210(2):298-305. PubMed ID: 7507853
[TBL] [Abstract][Full Text] [Related]
11. [Plasminogen activator inhibitors from neoplastic tissues].
Mirowski M; Wierzbicki R
Postepy Hig Med Dosw; 1991; 45(1-2):119-27. PubMed ID: 1923993
[TBL] [Abstract][Full Text] [Related]
12. Influence of nicotine and cotinine on the expression of plasminogen activator activity in bovine aortic endothelial cells.
Kuo BS; Dryjski M; Bjornsson TD
Thromb Haemost; 1989 Feb; 61(1):70-6. PubMed ID: 2501891
[TBL] [Abstract][Full Text] [Related]
13. Retinal pigment epithelium cells can influence endothelial cell plasminogen activators.
Moisseiev J; Jerdan JA; Dyer K; Maglione A; Glaser BM
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1070-8. PubMed ID: 2354910
[TBL] [Abstract][Full Text] [Related]
14. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.
Heidtmann HH; Hofmann M; Jacob E; Erbil C; Havemann K; Schwartz-Albiez R
Cancer Res; 1989 Dec; 49(24 Pt 1):6960-5. PubMed ID: 2555056
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
Moscatelli D
J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
18. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells.
Moscatelli D
J Cell Physiol; 1987 Apr; 131(1):123-30. PubMed ID: 3032990
[TBL] [Abstract][Full Text] [Related]
19. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte regulation of endothelial tissue plasminogen activator in a blood-brain barrier model.
Tran ND; Schreiber SS; Fisher M
J Cereb Blood Flow Metab; 1998 Dec; 18(12):1316-24. PubMed ID: 9850144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
